semaglutide news october 16 2025 India could soon get a lot thinner - at least in theory., On Friday, the patent on - the molecule behind Danish drugmaker Novo Nordisk’s blockbuster weight-loss drugs Wegovy and Ozempic Most quit breakthrough weight-loss drug

Botox People often receive Botulinum toxin (Botox) injections for cosmetic reasons, but it can also serve a medicinal purpose, such as managing chronic migraine

Despite consuming similar doses of alcohol calculated to increase breath alcohol concentration to approximately 0.08 percent, concentration increased more slowly in participants taking semaglutide, tirzepatide, or liraglutide

FRAP, ferric ion antioxidant power

Fischer M

Foundayo (Orforglipron) Approved in April 2026, Foundayo is the latest in GLP-1 weight loss medications

The implementation of the IRP model has raised concerns within the biopharmaceutical industry